Dramatic response of adult Wilms tumor to paclitaxel and cisplatin

Medical and Pediatric Oncology

Volumn 34, Issue 4, 2000, Pages 296-298

  Ramanathan, Ramesh K ^a   Rubin, Joshua T ^a   Ohori, N Paul ^b   Belani, Chandra P ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Adult Wilms tumor; Chemotherapy; Cisplatin; Kidney cancer; Paclitaxel

Indexed keywords

CARBOPLATIN; CISPLATIN; CREATININE; DACTINOMYCIN; DOXORUBICIN; PACLITAXEL; VINCRISTINE;

ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; LYMPHOPROLIFERATIVE DISEASE; NEPHROBLASTOMA; PRIORITY JOURNAL; TREATMENT OUTCOME; UREMIA;

ABDOMINAL NEOPLASMS; ADULT; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY NEOPLASMS; LUNG NEOPLASMS; PACLITAXEL; RADIOTHERAPY, ADJUVANT; WILMS TUMOR;

EID: 0034124040     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(200004)34:4<296::AID-MPO20>3.0.CO;2-P     Document Type: Article

References (9)

1. Arrigo S, Beckwith JB, Sharples K, et al. Better survival after combined modality care for adults with Wilms' tumor. A report from the National Wilms' Tumor Study. Cancer 1990;66:827-830.
2. de Camargo B, Melaragno R, Saba E, et al. Phase II study of carboplatin as a single drug for relapsed Wilms' tumor: experience of the Brazilian Wilms' Tumor Study Group. Med Pediatr Oncol 1994;22:258-260.
3. Tournade MF, Lemerle J, Brunat-Mentigny M, Bachelot C. Ifosfamide is an active drug in Wilms' tumor: a phase II study conducted by the French Society of Pediatric Oncology. J Clin Oncol 1988;6:793-796.
4. Pein F, Pinkerton R, Tournade MF, et al. Etoposide in relapsed or refractory Wilms' tumor: a phase II study by the French Society of Pediatric Oncology and the United Kingdom Children's Cancer Study Group. J Clin Oncol 1993;11:1478-1481.
5. Miser J, Krailo M, Hammond GD. The combination of ifosfamide (IFOS), etoposide (VP16), and mesna (M): a very active regimen in the treatment of recurrent Wilms' tumor (WT). Proc Am Soc Clin Oncol 1993;12:A1432 (abstract).
6. Pein F, Tournade MF, Zucker JM, et al. Etoposide and carboplatin: a highly effective combination in relapsed or refractory Wilms' tumor - a phase II study by the French Society of Pediatric Oncology. J Clin Oncol 1994;2:931-936.
7. Calvert AH, Newell DR, Grumbrell LA, et al. Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J Clin Oncol 1989;7:1748-1756
8. Donfrancesco A, Deb G, Sio L, et al. Phase I trial of a q4d Taxol regimen in pediatric patients with recurrent solid tumors. Proc Am Soc Clin Oncol 1994;13:A1463 (abstract).
9. Doz F, Gentet JC, Pein F, et al. Phase 1 Trial of paclitaxel in 3 hours (h) Infusion for children with refractory solid tumors: a SOF study. Proc Am Soc Clin Oncol 1996;15:A1466 (abstract).